Home
Axonics, Inc.

Axonics, Inc. Market Share Analysis for August 2026

Discover career opportunities at Boston Scientific. Here you will find purpose, a place to grow and together, we can advance science for life.

Health > Health - Other

Domainaxonics.com

Year Founded2012

Employees501 - 1000

Annual Revenue$200M - $500M

Axonics, Inc.

Axonics, Inc. (including company regionals)

axonics.com

See more website traffic and engagement information

Axonics, Inc. Revenue up to August 2026 is 200M - 500M

revenue generated by Axonics, Inc. top domains

Axonics, Inc. top domains revenue over 3 years

Revenue for Axonics, Inc. top domains

axonics.com200M - 500M

See more with Sales Intelligence

Total visits to Axonics, Inc.'s top domains

Understand Axonics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

axonics.com18.3K

See more with Sales Intelligence

Avg. visit duration in Axonics, Inc.'s top domains

Analyze Axonics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

axonics.com00:00:22

See more with Sales Intelligence

Avg. pageviews on Axonics, Inc.'s top domains

See how Axonics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

axonics.com1.48

See more with Sales Intelligence

Axonics, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

brainsway.comCompany NameBrainsWayEmployees51 - 200HQIsrael, jerusalemAnnual revenue$25M - $50MTotal visits109.6KHealth > Mental Health

Top technologies used by Axonics, Inc.

These are the website technologies, by industry, used by Axonics, Inc. top domains

Advertising (9)

DoubleClick

Conversion & Analytics (7)

Google Analytics

Widget (6)

Twemoji

Social (4)

Instagram

More Technologies

11

See all

News & Signals from Axonics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCohen retired from Axonics, Inc. as chief executive officer and member of the board of directors on Nov 1st '24.Cohen retired from Axonics following the November 2024 close of its $3.7 billion sale to Boston Scientific Corporation (NYSE: BSX).

NewsAxonics, Inc. recognized as No. 1 on the 2021 Deloitte Technology Fast 500(TM).Axonics ranked No. 1 on the 2021 Deloitte Technology Fast 500(TM) and the 2022 Financial Times ranking of the fastest growing companies in the Americas.

NewsAxonics, Inc. launched Axonics F15 recharge-free sacral neuromodulation system on Mar 14th '24.Medical technology company Axonics has announced receipt of Australia's Therapeutic Goods Administration's (TGA) approval for its Axonics F15 recharge-free sacral neuromodulation (SNM) system.